ASET TAKBERWUJUD Lanjutan INTANGIBLE ASSETS Continued

PT INDOFARMA PERSERO TBK PT INDOFARMA PERSERO TBK DAN ENTITAS ANAK AND SUBSIDIARY CATATAN ATAS LAPORAN KEUANGAN KONSOLIDASIAN NOTES TO CONSOLIDATED FINANCIAL STATETMENTS 31 Desember 2013 dan 2012 December 31, 2013 and, 2012 Untuk Tahun-tahun Yang Berakhir 31 Desember 2013 dan 2012 For the Years Ended December 31, 2013 and 2012 Dinyatakan dalam Rupiah Expressed in Full Rupiah 29. 29. ADDITIONAL PAID IN CAPITAL Biaya emisi Issuance costs of shares Opsi saham karyawan Employees stock option Nilai Bersih Net Value 30. 30. THE ALLOCATION OF NETT INCOME Pembagian dividen Distribution of dividends Pembentukan cadangan umum dan wajib App. for general and legal reserves Laba ditahan Retained Earnings Jumlah Total 31 31 NET SALES Lokal: Local: Obat Medicine Ethical Ethical Over the counter Over the counter Alat kesehatan Medicine devices Diagnostik Diagnostic Lain-lain Others Sub jumlah Sub total Ekspor: Exports: Ethical Ethical Over the counter Over the counter Sub jumlah Sub total Jumlah Total 12.910.489.813 13.465.248.582 13.108.352.366 23.037.064.058 Berdasarkan keputusan Rapat Umum Pemegang Saham Tahunan tanggal 11 April 2013 dan 15 Mei 2012, Pengalokasian laba neto masing-masing untuk tahun yang beakhir pada tanggal-tanggal 31 Desember 2012 dan 2011 adalah sebagai berikut: 2011 36.027.347.736 35.442.543.889 TAMBAHAN MODAL DISETOR 75.100.356.176 89.531.250.000 Initial public offering of 596,875,000 Shares with Rp100 per value per share, at Rp250 offering price per share 31 Desember 2012 December 31, 2012 89.531.250.000 1.142.585.008.138 There were no sales on the entity that exceeds 10 of total sales in the year ended December 31, 2013 and 2012. 448.593.750 14.879.487.574 14.879.487.574 448.593.750 In accordance with the resolutions of the Annual General Shareholders Meeting held on April 18, 2013 and May 15, 2012, the allocation of the net income for the years ended December 31, 2012 and 2011, respectively, are as follows: 1.324.389.839.343 Rincian pendapatan usaha berdasarkan kegiatan operasi Entitas induk dan anak adalah sebagai berikut: Dana Program Kemitraan dan Bina Lingkungan 863.231.990.940 31 Desember 2013 December 31, 2013 898.473.717.028 744.170.007 4.238.511.497 - Alokasi Dana PKBL dari laba tahun 2012 sebesar Rp847.702.300 merupakan biaya bina lingkungan yang akan langsung dibebankan pada laporan laba rugi tahun 2013 semester 2. PENJUALAN BERSIH Fund for Partnership and Environmental Development 83.283.091.708 31 Desember 2012 December 31 , 2012 - 847.702.300 12.721.078.575 Partnership and Environmental Development Fund allocation of profit in 2012 amounted to Rp847,702,300 is an environmental development costs that will be directly charged to the income statement in 2013 the 2nd half. Alokasi Dana PKBL dari laba tahun 2011 sebesar Rp1.476.772.662 dibayarkan oleh Perseroan di semester 2 tahun 2012 sebesar Rp738.386.331 dan dibayarkan di semester 1 tahun 2013 sebesar Rp738.386.331. Partnership and Environmental Development Fund allocation of profit in 2011 amounted to Rp1,476,772,662 paid by the Company in the 2nd half of 2012 amounted to Rp738,386,331 and paid in the 1st half of 2013 amounted to Rp738,386,331. 1.156.050.256.720 17.946.829.040 324.568.729.412 117.472.156 238.917.250.005 1.271.553.449 42.385.114.982 36.919.316.551 1.476.772.662 7.930.895.567 9.467.807.568 75.100.356.176 31 Desember 2013 December 31, 2013 2012 1.337.498.191.710 197.862.553 The details of revenue based on the company and its subsidiary s operations are as follows: Tidak terdapat penjualan pada satu entitas yang melebihi 10 dari total total penjualan pada tahun yang berakhir 31 Desember 2013 dan 2012. PENGGUNAAN LABA Penawaran umum perdana sebanyak 596.875.000 saham dengan nilai Nominal Rp100 per saham dengan Harga penawaran Rp250 per saham Halaman 48 Page